Search

everythinglearnresearchcommunity

for

Search:↓

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Non-obese women with hair loss have higher heart disease risk.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Tinea capitis is increasingly common in elderly women and requires accurate diagnosis with fungal cultures for effective treatment.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

INVERSION Femme supplement helped women lose weight, reduce hair loss, and improve skin and nail health.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

About 7% of Omani women visiting a gynecology clinic had polycystic ovarian syndrome, similar to rates in other countries.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

About 40% of women without hair loss and 60% with hair loss experience a lot of hair shedding, especially those under 50 with long hair.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

Hirsutism in young women is often caused by PCOS and managed with lifestyle changes, treatments, and hormonal therapy, which takes 9-12 months to work.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.